Skip to content
+1-516-222-6222
LCS@lachmanconsultants.com
Search
Location Selector

Current Location

  • - Global Website

  • - Ireland Website
  • Services
    • FDA-Related Services
    • Compliance
    • Regulatory Affairs
    • FDA 483 Response
    • Data Integrity
    • Mock FDA Inspections
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Remote Services From Lachman
  • Markets
    • Biologics
    • Advanced Therapies
    • Pharmaceuticals
    • Medical Devices
    • Related Industries
  • About
    • Lachman Leadership Team
    • Lachman Board of Directors
    • Careers
  • Blog & News
    • Blog
    • News
  • Contact
  • Resources
    • Lachman Learning
  • Location Selector
    • – Global Website
    • – Ireland Website

Omicron

Lachman Consultant Services, Inc. / Blog / Omicron
08
Dec

COVID-19 Variant Mutations Could Impact Test Results

By Bob Pollock    Dec 08, 2021    COVID-19 Omicron Testing

Yesterday, the FDA published a document (here) detailing potential impact on the performance of specific COVID-19 detection tests for the Omicron variant as well as other variants of SARS-CoV-2.  The FDA listed tests that may have reduced ability to detect the SARS-CoV-2 Omicron variant and provided a list of thirty‑three sites at which this test […]

Read More

Subscribe to our blog

Recent Articles

  • April 2026 Official OGD Statistical Report Issued
  • Hot Topics from FDLI’s 2026 Annual Conference: AI, Technology, Wearables, and Evolving FDA Inspections
  • FDA Commissioner Dr. Marty Makary Resigns

Contact Us:



Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA and industry experts has offered compliance, regulatory affairs, and technical services to clients around the world.
+1-516-222-6222
LCS@lachmanconsultants.com

 

Subscribe to our blog

Quick Links

  • Home
  • About
  • Services
  • Markets
  • Careers
  • Blog
  • Contact

Recent Posts

  • OGD Month report - image of analyzing statisticsApril 2026 Official OGD Statistical Report Issued
    May 15, 2026
  • Reagan Building in Washington DCHot Topics from FDLI’s 2026 Annual Conference: AI,…
    May 14, 2026
  • FDA HeadquartersFDA Commissioner Dr. Marty Makary Resigns
    May 12, 2026
2026 © Lachman Consultant Services, Inc.Terms and ConditionsPrivacy PolicyFCOI Policy
  • Services
    ▼
    • FDA-Related Services
    • Compliance
    • Regulatory Affairs
    • FDA 483 Response
    • Data Integrity
    • Mock FDA Inspections
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Remote Services From Lachman
  • Markets
    ▼
    • Biologics
    • Advanced Therapies
    • Pharmaceuticals
    • Medical Devices
    • Related Industries
  • About
    ▼
    • Lachman Leadership Team
    • Lachman Board of Directors
    • Careers
  • Blog & News
    ▼
    • Blog
    • News
  • Contact
  • Resources
    ▼
    • Lachman Learning
  • Location Selector
    ▼
    • – Global Website
    • – Ireland Website
Manage Consent

We use cookies and similar technologies to improve site performance, personalize content, analyze traffic, and for marketing purposes. You can accept all cookies, reject non-essential cookies, or manage your preferences. You may change or withdraw your consent at any time in our Cookie Settings.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}